UPDATED Mar 26, 2024
Companies with Return on Equity over 20%
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ZTST.F | US$0.17 | -4.5% | n/a | US$5.3m | n/a | PE6.8x | n/a | n/a | Tech | ||
FULO | US$0.24 | 19.7% | -37.0% | US$4.7m | n/a | PE9.7x | n/a | 5.5% | Telecom | ||
BMXI | US$0.031 | -23.5% | -71.8% | US$3.2m | n/a | PE0.4x | n/a | n/a | Materials | ||
FTRS | US$0.023 | -45.2% | -74.0% | US$3.0m | n/a | PE0.7x | n/a | n/a | Commercial Services | ||
RBCN | US$0.80 | 0% | -47.4% | US$1.9m | n/a | PE2.1x | n/a | n/a | Semiconductors | ||
ESMC | US$0.21 | -8.5% | 174.2% | US$1.6m | n/a | PE3.5x | n/a | n/a | Healthcare | ||
THRS.F | US$0.06 | 50.0% | n/a | US$1.4m | n/a | PE2.7x | n/a | n/a | Consumer Services | ||
LADX | US$2.30 | 29.9% | -74.5% | US$1.1m | n/a | PE6.4x | n/a | n/a | Pharmaceuticals & Biotech | ||
ATVK | US$0.0015 | -2.6% | -68.8% | US$816.5k | n/a | PE11.3x | n/a | n/a | Tech | ||
IDTA | US$0.13 | -10.9% | -62.8% | US$526.3k | n/a | PE3.2x | n/a | n/a | Tech | ||
CTKY.Y | US$0.04 | -34.5% | -84.0% | US$297.7k | n/a | PE0.6x | n/a | n/a | Software | ||
MXTS.F | US$0.0001 | 0% | n/a | US$27.6k | n/a | PE0.001x | n/a | n/a | Telecom |